PharmaCyte Biotech on Track to Commence Clinical Trials

Source:PharmaCyte Biotech, Inc. (OTCQB:PMCB) SILVER SPRING, Md., March 27, 2015 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box┬«, today announced that the genetically modified cells that are required for its three planned clinical trials have…

The post PharmaCyte Biotech on Track to Commence Clinical Trials appeared first on Marijuana Index.